• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[新型冠状病毒肺炎后持续性嗅觉障碍——德国耳鼻咽喉头颈外科学会嗅觉与味觉学工作组的建议]

[Persistent olfactory impairment after COVID-19-recommendations of the Working Group on Olfactology and Gustology of the German Society of Oto-rhino-laryngology, Head and Neck Surgery].

作者信息

Hintschich Constantin A, Wege-Lüssen Antje, Göktas Önder, Stuck Boris A, Müller Christian A, Hummel Thomas

机构信息

Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland.

Hals-Nasen-Ohrenklinik, Universitätsspital Basel, Basel, Schweiz.

出版信息

HNO. 2023 Nov;71(11):739-743. doi: 10.1007/s00106-023-01368-w. Epub 2023 Oct 6.

DOI:10.1007/s00106-023-01368-w
PMID:37801102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10589143/
Abstract

This article does not intend to comprehensively review the existing literature on coronavirus disease 2019 (COVID-19)-associated smell disorders, but aims to summarize scientific evidence for otorhinolaryngological practice and provide recommendations for diagnosis and treatment of persistent smell disorders following COVID-19.

摘要

本文无意全面综述关于2019冠状病毒病（COVID-19）相关嗅觉障碍的现有文献，而是旨在总结对耳鼻咽喉科临床实践有参考价值的科学证据，并为COVID-19后持续性嗅觉障碍的诊断和治疗提供建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623a/10589143/0c6662235eee/106_2023_1368_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623a/10589143/0c6662235eee/106_2023_1368_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623a/10589143/0c6662235eee/106_2023_1368_Fig1_HTML.jpg

相似文献

1
[Persistent olfactory impairment after COVID-19-recommendations of the Working Group on Olfactology and Gustology of the German Society of Oto-rhino-laryngology, Head and Neck Surgery].[新型冠状病毒肺炎后持续性嗅觉障碍——德国耳鼻咽喉头颈外科学会嗅觉与味觉学工作组的建议]
HNO. 2023 Nov;71(11):739-743. doi: 10.1007/s00106-023-01368-w. Epub 2023 Oct 6.
2
[Olfactory dysfunction. Epidemiology, pathophsiological classification, diagnosis and therapy].[嗅觉功能障碍。流行病学、病理生理分类、诊断与治疗]
HNO. 2004 Aug;52(8):679-84. doi: 10.1007/s00106-004-1117-x.
3
[Loss of smell, a preliminary indicator of COVID-19].[嗅觉丧失，新冠病毒病的一个初步指标]
Rev Med Inst Mex Seguro Soc. 2021 Feb 2;59(1):4-6. doi: 10.24875/RMIMSS.M21000046.
4
Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.COVID-19 相关持续性嗅觉丧失患者的经典嗅觉训练效果。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):757-763. doi: 10.1007/s00405-022-07570-w. Epub 2022 Jul 29.
5
[Diagnosis and Therapy of Olfactory Dysfunction - State of the ArtThe neglected sense-new evidence highlights the significance of the human sense of smell].嗅觉功能障碍的诊断与治疗——最新进展：被忽视的感觉——新证据凸显人类嗅觉的重要性
Wien Med Wochenschr. 2022 Feb;172(1-2):8-13. doi: 10.1007/s10354-021-00895-x. Epub 2021 Dec 1.
6
[Parosmia and phantosmia: clinical update].[嗅觉倒错与嗅觉幻觉：临床进展]
Rev Med Suisse. 2022 Oct 5;18(798):1837-1842. doi: 10.53738/REVMED.2022.18.798.1837.
7
[Recommendations for use of topical inhalant budesonide in COVID-19 : A position paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO). German version].[关于在新型冠状病毒肺炎中使用局部吸入性布地奈德的建议：德国应用变态反应学会（AeDA）和德国耳鼻咽喉头颈外科学会（DGHNO）的立场文件。德文版]
HNO. 2021 Aug;69(8):611-614. doi: 10.1007/s00106-021-01084-3. Epub 2021 Jun 17.
8
[Olfactory and gustatory disorders--causes, diagnosis and treatment].
MMW Fortschr Med. 2005 Mar 17;147(11):49, 51-3.
9
Recommendations for use of topical inhalant budesonide in COVID-19 : A Position Paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO).关于局部吸入性布地奈德在新冠病毒病中的应用建议：德国应用变态反应学会（AeDA）和德国耳鼻咽喉头颈外科学会（DGHNO）的立场文件
HNO. 2021 Aug;69(Suppl 2):35-38. doi: 10.1007/s00106-021-01070-9. Epub 2021 Jul 16.
10
The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.重视 COVID-19 大流行期间及临床实践中的嗅觉功能障碍
J Allergy Clin Immunol Pract. 2021 Jan;9(1):7-12. doi: 10.1016/j.jaip.2020.10.036. Epub 2020 Oct 28.

本文引用的文献

1
Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.SARS-CoV-2 病毒感染后嗅觉障碍的治疗。
Ear Nose Throat J. 2024 Jun;103(1_suppl):48S-53S. doi: 10.1177/01455613231168487. Epub 2023 Mar 28.
2
COVID-19-induced olfactory loss.新冠病毒感染所致嗅觉丧失。
J Allergy Clin Immunol. 2023 Apr;151(4):895-897. doi: 10.1016/j.jaci.2023.02.007. Epub 2023 Feb 21.
3
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.新冠感染后 6 个月持续的 COVID-19 症状和接种疫苗在 SARS-CoV-2 感染前后的作用。
JAMA Netw Open. 2023 Jan 3;6(1):e2251360. doi: 10.1001/jamanetworkopen.2022.51360.
4
The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts.变异株和疫苗接种对 SARS-CoV-2 症状学的影响：三项前瞻性家庭队列研究。
Int J Infect Dis. 2023 Mar;128:140-147. doi: 10.1016/j.ijid.2022.12.018. Epub 2022 Dec 23.
5
Parosmia as a predictor of a better olfactory function in COVID-19: a multicentric longitudinal study for upper respiratory tract infections.新冠病毒感染后嗅觉障碍与嗅觉功能转归的相关性：一项多中心前瞻性队列研究。
Eur Arch Otorhinolaryngol. 2023 May;280(5):2331-2340. doi: 10.1007/s00405-022-07781-1. Epub 2022 Dec 22.
6
Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.使用富含血小板的血浆治疗 COVID-19 相关嗅觉丧失：一项随机对照试验。
Int Forum Allergy Rhinol. 2023 Jun;13(6):989-997. doi: 10.1002/alr.23116. Epub 2022 Dec 21.
7
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.地塞米松治疗 COVID-19 后嗅觉功能障碍的随机、双盲、安慰剂对照试验。
BMC Med. 2022 Nov 16;20(1):445. doi: 10.1186/s12916-022-02625-5.
8
Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England.英格兰一项针对 1542510 名成年人的研究显示了 COVID-19 的变异特异性症状。
Nat Commun. 2022 Nov 11;13(1):6856. doi: 10.1038/s41467-022-34244-2.
9
Topical Administration of Mometasone Is Not Helpful in Post-COVID-19 Olfactory Dysfunction.莫米松局部给药对新冠后嗅觉功能障碍无效。
Life (Basel). 2022 Sep 24;12(10):1483. doi: 10.3390/life12101483.
10
Prevalence of olfactory dysfunction in D614G, alpha, delta and omicron waves: a psychophysical case-control study.D614G、α、δ和奥密克戎毒株感染时嗅觉功能障碍的患病率：一项心理物理学病例对照研究
Rhinology. 2023 Feb 1;61(1):32-38. doi: 10.4193/Rhin22.294.